Syrjänen K - Search Results

1

Prognostic value of mitotic counts in breast cancer of Saudi Arabian patients.

Buhmeida A, Al-Maghrabi J, Merdad A, Al-Thubaity F, Chaudhary A, Gari M, Abuzenadah A, Collan Y, Syrjänen K, Al-Qahtani M. Buhmeida A, et al. Among authors: syrjanen k. Anticancer Res. 2011 Jan;31(1):97-103. Anticancer Res. 2011. PMID: 21273586

2

Nuclear morphometry in prognostication of breast cancer in Saudi Arabian patients: comparison with European and African breast cancer.

Buhmeida A, Al-Maghrabi J, Merdad A, Al-Thubaity F, Chaudhary A, Gari M, Abuzenadah A, Collan Y, Syrjänen K, Al-Qahtani M. Buhmeida A, et al. Among authors: syrjanen k. Anticancer Res. 2010 Jun;30(6):2185-91. Anticancer Res. 2010. PMID: 20651368

3

RASSF1A methylation is predictive of poor prognosis in female breast cancer in a background of overall low methylation frequency.

Buhmeida A, Merdad A, Al-Maghrabi J, Al-Thobaiti F, Ata M, Bugis A, Syrjänen K, Abuzenadah A, Chaudhary A, Gari M, Al-Qahtani M, Dallol A. Buhmeida A, et al. Among authors: syrjanen k. Anticancer Res. 2011 Sep;31(9):2975-81. Anticancer Res. 2011. PMID: 21868547

4

Cyclooxygenase-2 expression as a predictor of outcome in colorectal carcinoma.

Al-Maghrabi J, Buhmeida A, Emam E, Syrjänen K, Sibiany A, Al-Qahtani M, Al-Ahwal M. Al-Maghrabi J, et al. Among authors: syrjanen k. World J Gastroenterol. 2012 Apr 21;18(15):1793-9. doi: 10.3748/wjg.v18.i15.1793. World J Gastroenterol. 2012. PMID: 22553404 Free PMC article.

5

Estrogen receptor, progesterone receptor, and nuclear size features in female breast cancer in Libya: correlation with clinical features and survival.

Abdalla FB, Markus R, Buhmeida A, Boder J, Syrjänen K, Collan Y. Abdalla FB, et al. Among authors: syrjanen k. Anticancer Res. 2012 Aug;32(8):3485-93. Anticancer Res. 2012. PMID: 22843935

6

Nuclear area is a prognostic determinant in advanced colorectal cancer.

Buhmeida A, Ristamäki R, Lamlum H, Bendardaf R, Heikkilä S, Collan Y, Syrjänen K, Pyrhönen S. Buhmeida A, et al. Among authors: syrjanen k. Anticancer Res. 2005 Jul-Aug;25(4):3083-8. Anticancer Res. 2005. PMID: 16080569 Free article.

7

Nuclear size as prognostic determinant in stage II and stage III colorectal adenocarcinoma.

Buhmeida A, Algars A, Ristamäki R, Collan Y, Syrjänen K, Pyrhönen S. Buhmeida A, et al. Among authors: syrjanen k. Anticancer Res. 2006 Jan-Feb;26(1B):455-62. Anticancer Res. 2006. PMID: 16739305 Free article.

8

Expression of cell cycle regulators p21 and p27 as predictors of disease outcome in colorectal carcinoma.

Al-Maghrabi J, Al-Ahwal M, Buhmeida A, Syrjänen K, Sibyani A, Emam E, Ghanim A, Al-Qahtani M. Al-Maghrabi J, et al. Among authors: syrjanen k. J Gastrointest Cancer. 2012 Jun;43(2):279-87. doi: 10.1007/s12029-011-9292-y. J Gastrointest Cancer. 2012. PMID: 21637966

9

VEGF-1 expression in colorectal cancer is associated with disease localization, stage, and long-term disease-specific survival.

Bendardaf R, Buhmeida A, Hilska M, Laato M, Syrjänen S, Syrjänen K, Collan Y, Pyrhönen S. Bendardaf R, et al. Among authors: syrjanen s, syrjanen k. Anticancer Res. 2008 Nov-Dec;28(6B):3865-70. Anticancer Res. 2008. PMID: 19192642 Free article.

10

High cyclooxygenase-2 expression is associated with advanced stages in colorectal cancer.

Elzagheid A, Emaetig F, Alkikhia L, Buhmeida A, Syrjänen K, El-Faitori O, Latto M, Collan Y, Pyrhönen S. Elzagheid A, et al. Among authors: syrjanen k. Anticancer Res. 2013 Aug;33(8):3137-43. Anticancer Res. 2013. PMID: 23898071

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

749 results

Search Page

Filters